BioSpace News Archive

Deals

Viking Therapeutics Announces Proposed Public Offering of Common Stock June 6, 2018

Viking Therapeutics, Inc. announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

June 6, 2018
·
5 min read
Deals

Mirati Therapeutics Announces Proposed Public Offering of Common Stock June 6, 2018

Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock.

June 6, 2018
·
4 min read
Drug Development

Proteostasis Announces Positive Data from Ongoing Phase 1 Study of PTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy

Proteostasis Therapeutics, Inc. announced positive results from the Company’s ongoing 14-day dosing study of PTI-801 in CF patients on background Orkambi® (lumacaftor/ivacaftor) therapy.

June 6, 2018
·
13 min read
Genetown

Vertex to Present at the Goldman Sachs Healthcare Conference on June 13

Vertex Pharmaceuticals Incorporated announced that management will present at the Goldman Sachs Healthcare Conference

June 6, 2018
·
1 min read
Deals

Fortive Announces Binding Offer to Acquire the Advanced Sterilization Products Business from Johnson & Johnson for Approximately $2.7 Billion in Cash

Fortive Corporation announced that it has made a binding offer to Ethicon, Inc.

June 6, 2018
·
7 min read
Policy

FDA seeks permanent injunction against company selling unapproved hand sanitizers that claim to prevent infections from numerous pathogens

The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company’s president and chief executive officer

June 6, 2018
·
2 min read
BioCapital

BAHP: WVE Report Unsubstantiated, Based on Misinformation

Product ingredient safety a high priority for BAHP member companies

June 6, 2018
·
2 min read
Deals

Seroquel Stepping Stone: How Luye Will Use Seroquel to Expand in Emerging Markets

The $538 million acquisition by Luye Pharma Group Ltd. (HKSE:2186) of Seroquel quetiapine fumarate from AstraZeneca plc (LSE:AZN; NYSE:AZN) will lay the commercial groundwork in new emerging markets for the Chinese pharma’s internal CNS pipeline.

June 6, 2018
·
2 min read
Business

Sonion and Valencell Partner to Make Biometrics Universal in Hearables and Hearing Health Markets

Market leaders joining forces to accelerate innovation in the rapidly expanding market for health, medical and consumer devices

June 6, 2018
·
4 min read
Policy

Serco Awarded Center for Medicare and Medicaid Contract Supporting Health Benefit Exchanges

Serco Inc. announced that the Company has been awarded a contract by the U.S. Department of Health and Human Services, Center for Medicare and Medicaid Services (CMS) to continue supporting eligibility determinations for consumers purchasing health insurance through the Federal Health Insurance Exchanges.

June 6, 2018
·
2 min read